Literature DB >> 26091947

Mass weighted urn design--A new randomization algorithm for unequal allocations.

Wenle Zhao1.   

Abstract

Unequal allocations have been used in clinical trials motivated by ethical, efficiency, or feasibility concerns. Commonly used permuted block randomization faces a tradeoff between effective imbalance control with a small block size and accurate allocation target with a large block size. Few other unequal allocation randomization designs have been proposed in literature with applications in real trials hardly ever been reported, partly due to their complexity in implementation compared to the permuted block randomization. Proposed in this paper is the mass weighted urn design, in which the number of balls in the urn equals to the number of treatments, and remains unchanged during the study. The chance a ball being randomly selected is proportional to the mass of the ball. After each treatment assignment, a part of the mass of the selected ball is re-distributed to all balls based on the target allocation ratio. This design allows any desired optimal unequal allocations be accurately targeted without approximation, and provides a consistent imbalance control throughout the allocation sequence. The statistical properties of this new design is evaluated with the Euclidean distance between the observed treatment distribution and the desired treatment distribution as the treatment imbalance measure; and the Euclidean distance between the conditional allocation probability and the target allocation probability as the allocation predictability measure. Computer simulation results are presented comparing the mass weighted urn design with other randomization designs currently available for unequal allocations.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allocation predictability; Mass weighted urn design; Treatment imbalance; Unequal allocation

Mesh:

Year:  2015        PMID: 26091947      PMCID: PMC4522356          DOI: 10.1016/j.cct.2015.06.008

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  12 in total

1.  Preserving the allocation ratio at every allocation with biased coin randomization and minimization in studies with unequal allocation.

Authors:  Olga M Kuznetsova; Yevgen Tymofyeyev
Journal:  Stat Med       Date:  2011-12-12       Impact factor: 2.373

2.  A simplified formula for quantification of the probability of deterministic assignments in permuted block randomization.

Authors:  Wenle Zhao; Yanqiu Weng
Journal:  J Stat Plan Inference       Date:  2011-01-01       Impact factor: 1.111

Review 3.  The use of unequal randomisation ratios in clinical trials: a review.

Authors:  J C Dumville; S Hahn; J N V Miles; D J Torgerson
Journal:  Contemp Clin Trials       Date:  2005-10-19       Impact factor: 2.226

4.  Efficient generation of constrained block allocation sequences.

Authors:  Ibrahim Salama; Anastasia Ivanova; Bahjat Qaqish
Journal:  Stat Med       Date:  2008-04-30       Impact factor: 2.373

5.  Minimizing predictability while retaining balance through the use of less restrictive randomization procedures.

Authors:  Vance W Berger; Anastasia Ivanova; Maria Deloria Knoll
Journal:  Stat Med       Date:  2003-10-15       Impact factor: 2.373

6.  Wide brick tunnel randomization - an unequal allocation procedure that limits the imbalance in treatment totals.

Authors:  Olga M Kuznetsova; Yevgen Tymofyeyev
Journal:  Stat Med       Date:  2013-12-03       Impact factor: 2.373

7.  Brick tunnel randomization for unequal allocation to two or more treatment groups.

Authors:  Olga M Kuznetsova; Yevgen Tymofyeyev
Journal:  Stat Med       Date:  2011-01-13       Impact factor: 2.373

8.  A better alternative to stratified permuted block design for subject randomization in clinical trials.

Authors:  Wenle Zhao
Journal:  Stat Med       Date:  2014-07-14       Impact factor: 2.373

Review 9.  Block urn design - a new randomization algorithm for sequential trials with two or more treatments and balanced or unbalanced allocation.

Authors:  Wenle Zhao; Yanqiu Weng
Journal:  Contemp Clin Trials       Date:  2011-08-22       Impact factor: 2.226

10.  Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus.

Authors:  Jason T Connor; Jordan J Elm; Kristine R Broglio
Journal:  J Clin Epidemiol       Date:  2013-08       Impact factor: 6.437

View more
  6 in total

1.  Implementing Optimal Designs for Dose-Response Studies Through Adaptive Randomization for a Small Population Group.

Authors:  Yevgen Ryeznik; Oleksandr Sverdlov; Andrew C Hooker
Journal:  AAPS J       Date:  2018-07-19       Impact factor: 4.009

2.  Time-trend impact on treatment estimation in two-arm clinical trials with a binary outcome and Bayesian response adaptive randomization.

Authors:  Yunyun Jiang; Wenle Zhao; Valerie Durkalski-Mauldin
Journal:  J Biopharm Stat       Date:  2019-04-24       Impact factor: 1.051

3.  A randomized trial to compare exercise treatment methods for patients after total knee replacement: protocol paper.

Authors:  Sara R Piva; Charity G Moore; Michael Schneider; Alexandra B Gil; Gustavo J Almeida; James J Irrgang
Journal:  BMC Musculoskelet Disord       Date:  2015-10-16       Impact factor: 2.362

4.  Generalization of Wei's urn design to unequal allocations in sequential clinical trials.

Authors:  Wenle Zhao; Viswanathan Ramakrishnan
Journal:  Contemp Clin Trials Commun       Date:  2016-04-15

5.  Effectiveness of Later-Stage Exercise Programs vs Usual Medical Care on Physical Function and Activity After Total Knee Replacement: A Randomized Clinical Trial.

Authors:  Sara R Piva; Michael J Schneider; Charity G Moore; M Beatriz Catelani; Alexandra B Gil; Brian A Klatt; Anthony M DiGioia; Gustavo J Almeida; Samannaaz S Khoja; Gwendolyn Sowa; James J Irrgang
Journal:  JAMA Netw Open       Date:  2019-02-01

6.  Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial.

Authors: 
Journal:  Lancet       Date:  2022-01-28       Impact factor: 202.731

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.